Erratum: Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia (Blood Cancer Journal (2014) 4 (e237) DOI: 10.1038/bcj.2014.59)

K. D. Cummins; S. M. Jane; S. Ninkovic; Ali Bazargan; Robin J A Filshie; G Sutrave; Mark Hertzberg; A. Scott; S. Lane; C. K. Yannakou; Peter D. Ritchie; J. D'Rozario; J. Black; Ketan Bavishi; A. Wei

doi:10.1038/bcj.2014.68

Erratum: Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia (Blood Cancer Journal (2014) 4 (e237) DOI: 10.1038/bcj.2014.59)

K. D. Cummins, S. M. Jane, S. Ninkovic, Ali Bazargan, Robin J A Filshie, G Sutrave, Mark Hertzberg, A. Scott, S. Lane, C. K. Yannakou, Peter D. Ritchie, J. D'Rozario, J. Black, Ketan Bavishi, A. Wei

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Original language	English
Article number	e246
Journal	Blood Cancer Journal
Volume	4
Issue number	9
DOIs	https://doi.org/10.1038/bcj.2014.68
Publication status	Published - 1 Jan 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/bcj.2014.68

Cite this

Cummins, K. D., Jane, S. M., Ninkovic, S., Bazargan, A., Filshie, R. J. A., Sutrave, G., Hertzberg, M., Scott, A., Lane, S., Yannakou, C. K., Ritchie, P. D., D'Rozario, J., Black, J., Bavishi, K., & Wei, A. (2014). Erratum: Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia (Blood Cancer Journal (2014) 4 (e237) DOI: 10.1038/bcj.2014.59). Blood Cancer Journal, 4(9), [e246]. https://doi.org/10.1038/bcj.2014.68

@article{9491910fb6004c698b12e05537595a24,

title = "Erratum: Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia (Blood Cancer Journal (2014) 4 (e237) DOI: 10.1038/bcj.2014.59)",

author = "Cummins, {K. D.} and Jane, {S. M.} and S. Ninkovic and Ali Bazargan and Filshie, {Robin J A} and G Sutrave and Mark Hertzberg and A. Scott and S. Lane and Yannakou, {C. K.} and Ritchie, {Peter D.} and J. D'Rozario and J. Black and Ketan Bavishi and A. Wei",

year = "2014",

month = jan,

day = "1",

doi = "10.1038/bcj.2014.68",

language = "English",

volume = "4",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "9",

}

Cummins, KD, Jane, SM, Ninkovic, S, Bazargan, A, Filshie, RJA, Sutrave, G, Hertzberg, M, Scott, A, Lane, S, Yannakou, CK, Ritchie, PD, D'Rozario, J, Black, J, Bavishi, K & Wei, A 2014, 'Erratum: Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia (Blood Cancer Journal (2014) 4 (e237) DOI: 10.1038/bcj.2014.59)', Blood Cancer Journal, vol. 4, no. 9, e246. https://doi.org/10.1038/bcj.2014.68

Erratum : Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia (Blood Cancer Journal (2014) 4 (e237) DOI: 10.1038/bcj.2014.59). / Cummins, K. D.; Jane, S. M.; Ninkovic, S. et al.

In: Blood Cancer Journal, Vol. 4, No. 9, e246, 01.01.2014.

Research output: Contribution to journal › Comment / Debate › Other › peer-review

TY - JOUR

T1 - Erratum

T2 - Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia (Blood Cancer Journal (2014) 4 (e237) DOI: 10.1038/bcj.2014.59)

AU - Cummins, K. D.

AU - Jane, S. M.

AU - Ninkovic, S.

AU - Bazargan, Ali

AU - Filshie, Robin J A

AU - Sutrave, G

AU - Hertzberg, Mark

AU - Scott, A.

AU - Lane, S.

AU - Yannakou, C. K.

AU - Ritchie, Peter D.

AU - D'Rozario, J.

AU - Black, J.

AU - Bavishi, Ketan

AU - Wei, A.

PY - 2014/1/1

Y1 - 2014/1/1

UR - http://www.scopus.com/inward/record.url?scp=84927745055&partnerID=8YFLogxK

U2 - 10.1038/bcj.2014.68

DO - 10.1038/bcj.2014.68

M3 - Comment / Debate

AN - SCOPUS:84927745055

VL - 4

JO - Blood Cancer Journal

JF - Blood Cancer Journal

SN - 2044-5385

IS - 9

M1 - e246

ER -

Erratum: Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia (Blood Cancer Journal (2014) 4 (e237) DOI: 10.1038/bcj.2014.59)

UN SDGs

Access to Document

Other files and links

Cite this